Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Mediking Biopharm is a professional Contract Research Organization (CRO) based in China, providing comprehensive clinical development services to the global pharmaceutical and biotechnology industries. Founded in 2004, the company specializes in managing Phase I-IV clinical trials, with a particular emphasis on navigating the Chinese regulatory environment (NMPA). Their service portfolio includes clinical trial operations, regulatory affairs, medical writing, data management, and biostatistics. Mediking Biopharm has built an extensive network of hospital sites and clinical experts across China, facilitating efficient trial execution for both domestic and international clients. By offering integrated clinical solutions, the company plays a vital role in accelerating the market entry of innovative therapies in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediking Biopharm.